European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - live aroa-gene deleted escherichia coli,type o78,ec34195 - unknown - live aroa-gene deleted escherichia coli,type o78,ec34195 vaccine-microbial active 0.0 - active constituent

New Zealand - English - Ministry for Primary Industries

elanco australasia pty ltd - escherichia coli (inactivated) - escherichia coli (inactivated) 0 vaccine - vaccine

United States - English - NLM (National Library of Medicine)

energique, inc. - escherichia coli (unii: 514b9k0l10) (escherichia coli - unii:514b9k0l10) - escherichia coli 30 [hp_c] in 1 ml - may temporarily relieve diarrhea and nausea.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve diarrhea and nausea.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs

Philippines - English - FDA (Food And Drug Administration)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated escherichia coli fimbrial adhesin (f4ab, f4ac, f5 and f6) , heat labile (lt) enterotoxoid , clotridium perfringens (type c) b toxoid , clostridium novyi (type b) a toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response.

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens b-toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum)

Philippines - English - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated clostridium perfringens , escherichia coli vaccine (vet.) - solution for injection (im) - each 2 ml (dose) contains: clostridium perfringens (type c) ............ escherichia coli k99 (b44 strain) ...... escherichia coli k99 + f41 (b41 strain) ... escherichia coli k88, (1769 strain) .................. escherichia coli 987p (1592 strain) ............... cpu-colony plate unit od-optical density 2621 cpu 20.53 od 23.7 od 21.8 od 23.8 od